Policy Updates Medical Policy & Clinical GuidelinesMedicaid Managed CareMarch 26, 2025

Medical Policies and Clinical Utilization Management Guidelines update

Effective April 28, 2025

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third‑Party Criteria below were developed and/or revised during Quarter Three, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary.

Please share this notice with other members of your practice and office staff.

To view a guideline, visit the Medical Policies & Clinical UM Guidelines website.

Medical Policies

The Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect April 28, 2025.

Publish date

Medical Policy number

Medical Policy title

Status

10/1/2024

DME.00011

Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices

Revised

10/1/2024

DME.00052

Brain Computer Interface Rehabilitation Devices

New

10/1/2024

LAB.00026

Systems Pathology and Multimodal Artificial Intelligence Testing for Cancerous and Precancerous Conditions

Previously titled: Systems Pathology and Multimodal Artificial Intelligence Testing for Prostate Cancer

Revised

10/1/2024

SURG.00157

Minimally Invasive Treatment of the Posterior Nasal Nerve to Treat Rhinitis

Reviewed

Clinical UM Guidelines

The MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members. These guidelines take effect April 28, 2025.

Publish date

Clinical UM Guideline number

Clinical UM Guideline title

Status

10/1/2024

CG-DME-48

Vacuum Assisted Wound Therapy in the Outpatient Setting

Reviewed

10/1/2024

CG-LAB-33

Carcinoembryonic Antigen Testing

New

10/1/2024

CG-LAB-35

Cancer Antigen 19-9 Testing

New

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

OHBCBS-CD-077801-25

PUBLICATIONS: April 2025 Provider Newsletter